Abstract:Down syndrome (DS) is the most example of aneuploidy, resulting from an additional copy of all or part of chromosome 21. Competing endogenous RNAs (ceRNAs) play important roles in neuronal development and neurological defects. This study aimed to identify hub genes and synergistic crosstalk among ceRNAs in the DS fetal hippocampus as potential targets for the treatment of DS-related neurodegenerative diseases. We profiled differentially expressed long non-coding RNAs (DElncRNAs), differentially expressed circular RNAs (DEcircRNAs), differentially expressed microRNAs (DEmiRNAs), and differentially expressed messenger RNAs (DEmRNAs) in hippocampal samples from patients with or without DS. Functional enrichment analysis and gene set enrichment analysis were performed, and chromosome 21-related ceRNA and protein–protein interaction networks were constructed. Additionally, the correlations between lncRNA-mRNA and miRNA-mRNA expression in the samples and HEK293T cells were validated. Our finding of changes in the expression of some key genes and ncRNAs on chromosome 21 in DS might not fully conform to the gene dosage hypothesis. Moreover, we found that four lncRNAs ( MIR99AHG , PLCB4 , SNHG14 , GIGYF2 ) and one circRNA ( hsa_circ_0061697 ) may competitively bind with three miRNAs ( hsa-miR-548b-5p , miR-730-5p , and hsa-miR-548i ) and subsequently regulate five mRNAs ( beta-1,3-galactosyltransferase 5 [ B3GALT5 ], helicase lymphoid-specific [ HELLS ], thrombospondin-2 [ THBS2 ], glycinamide ribonucleotide transformylase [ GART ], clathrin heavy chain like 1 [ CLTCL1 ]). These RNAs, whether located on chromosome 21 or not, interact with each other and might activate the PI3K/Akt/mTOR and Wnt signaling pathways, which are involved in autophagosome formation and tau hyperphosphorylation, possibly leading to adverse consequences of trisomy 21. These findings provide researchers with a better understanding of the fundamental molecular mechanisms underlying DS-related progressive defects in neuronal development.

The lncRNA Snhg11 , a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome

Single-nucleus RNA sequencing reveals cell type-specific transcriptome alterations of Down syndrome hippocampus using the Dp16 mouse model

Competing Endogenous RNAs Crosstalk in Hippocampus: A Potential Mechanism for Neuronal Developing Defects in Down Syndrome

Human Chromosome 21 Orthologous Region on Mouse Chromosome 17 is a Major Determinant of Down Syndrome-Related Developmental Cognitive Deficits.

Abnormal MicroRNA Expression in Ts65Dn Hippocampus and Whole Blood: Contributions to Down Syndrome Phenotypes

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Cognitive and molecular characterization of the Ts66Yah murine model of Down syndrome: deepening on hippocampal changes associated with genotype and aging

Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome

Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination

Detection and Functional Annotation of Misregulated Micrornas in the Brain of the Ts65Dn Mouse Model of Down Syndrome.

Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice

Role of long non-coding RNAs in Down syndrome patients: a transcriptome analysis study

Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation

DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models

Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model

Forebrain Shh overexpression improves cognitive function in a Down syndrome mouse model and euploid littermates

Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome

Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome

Mirna-155 Upregulation and Complement Factor H Deficits in Down’s Syndrome

A Novel Mechanism Underlying Pathogenesis of Down Syndrome